Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland.
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Med Phys. 2024 Jun;51(6):4095-4104. doi: 10.1002/mp.17076. Epub 2024 Apr 17.
Contrast-enhanced computed tomography (CECT) provides much more information compared to non-enhanced CT images, especially for the differentiation of malignancies, such as liver carcinomas. Contrast media injection phase information is usually missing on public datasets and not standardized in the clinic even in the same region and language. This is a barrier to effective use of available CECT images in clinical research.
The aim of this study is to detect contrast media injection phase from CT images by means of organ segmentation and machine learning algorithms.
A total number of 2509 CT images split into four subsets of non-contrast (class #0), arterial (class #1), venous (class #2), and delayed (class #3) after contrast media injection were collected from two CT scanners. Seven organs including the liver, spleen, heart, kidneys, lungs, urinary bladder, and aorta along with body contour masks were generated by pre-trained deep learning algorithms. Subsequently, five first-order statistical features including average, standard deviation, 10, 50, and 90 percentiles extracted from the above-mentioned masks were fed to machine learning models after feature selection and reduction to classify the CT images in one of four above mentioned classes. A 10-fold data split strategy was followed. The performance of our methodology was evaluated in terms of classification accuracy metrics.
The best performance was achieved by Boruta feature selection and RF model with average area under the curve of more than 0.999 and accuracy of 0.9936 averaged over four classes and 10 folds. Boruta feature selection selected all predictor features. The lowest classification was observed for class #2 (0.9888), which is already an excellent result. In the 10-fold strategy, only 33 cases from 2509 cases (∼1.4%) were misclassified. The performance over all folds was consistent.
We developed a fast, accurate, reliable, and explainable methodology to classify contrast media phases which may be useful in data curation and annotation in big online datasets or local datasets with non-standard or no series description. Our model containing two steps of deep learning and machine learning may help to exploit available datasets more effectively.
与非增强 CT 图像相比,增强 CT(CECT)提供了更多信息,特别是对于区分肝癌等恶性肿瘤。即使在同一地区和语言中,公共数据集上通常也缺少对比剂注射相信息,临床也没有标准化。这是有效利用现有 CECT 图像进行临床研究的障碍。
本研究旨在通过器官分割和机器学习算法从 CT 图像中检测对比剂注射相。
从两台 CT 扫描仪中收集了总共 2509 张 CT 图像,这些图像分为非对比(第 0 类)、动脉(第 1 类)、静脉(第 2 类)和延迟(第 3 类)四个子集。通过预训练的深度学习算法生成了包括肝脏、脾脏、心脏、肾脏、肺、膀胱和主动脉在内的七个器官,以及身体轮廓掩模。随后,从上述掩模中提取了五个一阶统计特征,包括平均值、标准差、10%、50%和 90%百分位数,经过特征选择和降维后,将这些特征输入机器学习模型,以将 CT 图像分类为上述四个类别之一。采用 10 折数据分割策略。我们的方法的性能是通过分类准确性指标来评估的。
Boruta 特征选择和 RF 模型的表现最好,四个类别和 10 折的平均曲线下面积均超过 0.999,准确率为 0.9936。Boruta 特征选择选择了所有预测特征。分类效果最差的是第 2 类(0.9888),这已经是一个非常优秀的结果。在 10 折策略中,2509 例中只有 33 例(约 1.4%)被误分类。所有折叠的性能都一致。
我们开发了一种快速、准确、可靠且可解释的方法来分类对比剂相,这可能对大型在线数据集或无系列描述的本地数据集的数据整理和注释有用。我们的模型包含深度学习和机器学习的两个步骤,可能有助于更有效地利用现有数据集。